MUC1 and breast cancer: The cell viability of breast cancer cells and fibroblasts was measured by the method of Carmichael et al. [14], in order to compare cytotoxicity of Pt12, cisplatin, Pt12 with anti-MUC1 and cisplatin with anti-MUC1 (Figs. 2, 3).